Stockscreener 앱 받기
8.71
9.70%
0.77
시장 영업 전:
8.71
Fibrogen Inc 주식(FGEN)의 최신 뉴스
Fibrogen FGEN 2025Q2 Earnings Preview Upside Potential on Strong Revenue Growth - AInvest
FibroGen shares surge on FDA support for anemia drug in MDS patients - MSN
Is FibroGen Inc. affected by consumer sentimentRocket Return Picks - thegnnews.com
FibroGen Inc expected to post a loss of $2.31 a shareEarnings Preview - TradingView
FibroGen shares rise 11.75% intraday after positive FDA meeting for roxadustat Phase 3 trial. - AInvest
Fibrogen: HC Wainwright Raises PT to $43 from $10, Maintains Buy Rating - AInvest
FibroGen stock surges after FDA feedback on roxadustat for MDS anemia - Investing.com India
FibroGen advances roxadustat for anemia in myelodysplastic syndromes By Investing.com - Investing.com Australia
FibroGen advances roxadustat for anemia in myelodysplastic syndromes - Investing.com
FibroGen Announces Positive Type C Meeting with the FDA for - GlobeNewswire
FDA Green-Lights FibroGen's Novel Oral Treatment for MDS Anemia: 5x Better Than Placebo - Stock Titan
FibroGen, Inc. (NASDAQ:FGEN) Q4 2024 Earnings Call Transcript - MSN
FibroGen to Report Second Quarter 2025 Financial Results - The Manila Times
FibroGen Q2 2025 Earnings Call: Key Financial Results Coming August 11 After Market Close - Stock Titan
How does FibroGen Inc. compare to its industry peersHigh-yield growth strategies - Jammu Links News
How volatile is FibroGen Inc. stock compared to the marketCapitalize on market trends with confidence - Jammu Links News
What is the dividend policy of FibroGen Inc. stockInvest confidently with professional guidance - Jammu Links News
Is FibroGen Inc. a good long term investmentRapidly growing investment returns - Jammu Links News
How does FibroGen Inc. generate profit in a changing economyGet exclusive access to premium stock research - Jammu Links News
What institutional investors are buying FibroGen Inc. stockCapitalize on momentum-driven stocks - Jammu Links News
What are analysts’ price targets for FibroGen Inc. in the next 12 monthsLightning-fast capital gains - Jammu Links News
Should I hold or sell FibroGen Inc. stock in 2025Get real-time updates on market trends - Jammu Links News
What are the latest earnings results for FibroGen Inc.Consistent triple-digit returns - Jammu Links News
What is the risk reward ratio of investing in FibroGen Inc. stockRealize exceptional returns through smart trading - Jammu Links News
How strong is FibroGen Inc. company’s balance sheetCapitalize on market shifts with expert advice - Jammu Links News
Press Release: FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update - 富途牛牛
Applying big data sentiment scoring on FibroGen Inc.Quick Gain Stock Watch With Indicators Reviewed - metal.it
Short Interest Drops in FibroGen Inc. After RallyMarket Momentum Signal Generator Shows Trends - beatles.ru
FibroGen Inc. Recovery Potential Based on Technical ToolsTechnical Entry Strategy for Beginners Explained - metal.it
Sector Leaders Rotate Capital Into FibroGen Inc.Trade Timing Strategy With Technical Data Explained - metal.it
FibroGen Inc. Hits Oversold Level on RSI IndicatorConsistent Profit Pattern Recognition Tools Shared - metal.it
Published on: 2025-07-29 03:32:03 - metal.it
What are FibroGen Inc. company’s key revenue driversUnprecedented profits - Jammu Links News
Is FibroGen Inc. a growth stock or a value stockUnmatched market performance - jammulinksnews.com
What are the technical indicators suggesting about FibroGen Inc.Consistent wealth multiplication - jammulinksnews.com
Is it the right time to buy FibroGen Inc. stockExplosive returns - jammulinksnews.com
What makes FibroGen Inc. stock price move sharplyCarefully Curated High Return Stocks - metal.it
Why FibroGen Inc. stock attracts strong analyst attentionFree VIP Investment Strategies - metal.it
FibroGen Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia
Will FibroGen Inc. stock split in the near futureSuperior portfolio returns - jammulinksnews.com
0.24%
3.39%
자본화:
|
볼륨(24시간):